Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801).
Journal: AJNR. American journal of neuroradiology
Published: February 19, 2026
CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.
Journal: Neuro-oncology advances
Published: August 04, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS Lymphoma.
Journal: Neuro-oncology
Published: August 04, 2025
Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas.
Journal: Neuro-oncology
Published: July 14, 2025
Enhancing clinical decision-making: An externally validated machine learning model for predicting isocitrate dehydrogenase mutation in gliomas using radiomics from presurgical magnetic resonance imaging.
Journal: Neuro-oncology advances
Published: December 11, 2024
Advances in Primary Central Nervous System Lymphoma.
Journal: Current neurology and neuroscience reports
Published: October 19, 2024
Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach.
Journal: Cancers
Published: April 03, 2024
Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype Prediction.
Journal: AJNR. American journal of neuroradiology
Published: February 27, 2023
Last Updated: 09/26/2026